Search Results - "Makinen, Shawn"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE) by Makinen, Shawn R, Zhu, Qin, Davis, Heather L, Weeratna, Risini D

    Published in International immunology (01-09-2016)
    “…Adjuvants are a key component in enhancing immunogenicity of vaccines and play a vital role in facilitating the induction of the correct type of immunity…”
    Get full text
    Journal Article
  3. 3

    Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse by Vicari, Alain P, Luu, Rachel, Zhang, Ningli, Patel, Shobhna, Makinen, Shawn R, Hanson, Douglas C, Weeratna, Risini D, Krieg, Arthur M

    Published in Cancer Immunology, Immunotherapy (01-04-2009)
    “…The anti-tumor properties of Toll-like receptor (TLR) 9 agonist CpG oligodeoxynucleotides (ODN) are enhanced by combinations with several cytotoxic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848) by Weeratna, Risini D., Makinen, Shawn R., McCluskie, Michael J., Davis, Heather L.

    Published in Vaccine (01-11-2005)
    “…TLR ligands that mimic pathogen associated molecular patterns and activate immune cells via Toll-like receptors (TLRs) are being developed for use in humans as…”
    Get full text
    Journal Article
  6. 6

    In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity by Anderson, Richard J, Guru, Siradanahalli, Weeratna, Risini, Makinen, Shawn, Falconer, Derek J, Sheppard, Neil C, Lang, Susanne, Chang, Bingsheng, Goenaga, Anne-Laure, Green, Bruce A, Merson, James R, Gracheck, Stephen J, Eyles, Jim E

    Published in Vaccine (07-12-2016)
    “…Highlights • Immunizing efficacy of 52 pneumococcal proteins evaluated in a mouse challenge model. • Proteins were selected based on genetic conservation and…”
    Get full text
    Journal Article
  7. 7

    CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γ Responses by Drane, Debbie, Makinen, Shawn, Evans, Dana M., Weeratna, Risini D., McCluskie, Michael J., Davis, Heather L.

    Published in BioMed research international (01-01-2013)
    “…For the induction of robust humoral and cellular immune responses, a strong rationale exists to use vaccine-adjuvant combinations possessing both immune…”
    Get full text
    Journal Article
  8. 8